ROTA PHARM MARKETING LP
Opportunity 63/100 (worth a look), bankability 75/100. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Resolve: No active directors on record. Company is active but has no current directors in the register. This is unusual and should be investigated. Most likely exit: share sale to pe / searcher (58/100).
Data confidence
Overall: low (30/100)Sparse data coverage. Treat AI-generated outputs as preliminary. Manual diligence essential.
Mixed signal. Worth opening the full target workup before deciding to pursue.
Recent activity
Corporate timeline (3 events)Click to expand
- 2017-07-17📄legacyincorporation · LP6
- 2011-04-20🏢Company incorporatedAs ROTA PHARM MARKETING LP
- 2011-04-20📄legacyincorporation · LP5
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
- +No director turnover: Company is 15 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- secondaryStable-but-static management: Company is 15 years old and no new directors in the last 3 years — succession not yet being planned internally.
Red flags
1 high ·Company is active but has no current directors in the register. This is unusual and should be investigated.
Similar companies
Active · same sector · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| SL007479 LP→ SL007479 · est 2009 · no financials extracted | — | — | — | — | 16y | — | — |
| SL015701 LP→ SL015701 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
| SL020366 LP→ SL020366 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| SL023721 LP→ SL023721 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| SL023786 LP→ SL023786 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| SL024024 LP→ SL024024 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| SL024848 LP→ SL024848 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| SL024849 LP→ SL024849 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| SL025238 LP→ SL025238 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| SL025239 LP→ SL025239 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| SL025240 LP→ SL025240 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| SL025241 LP→ SL025241 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →